To achieve this, we established a supply chain team to analyze incremental volume, optimize purchase pricing and evaluate product and line extensions in sports nutrition areas that command higher margins. Longer-term (over the course of the next two to three years) we plan to ramp up internal production through vertical integration of manufacturing.
So in 10-15 years we will have our own manufacturing.
Pharmaceutical delivery systems can be used by sports nutrition.
Some can anyway.
The Biozone acquisition is strategic in that it gives Muscle Pharm ownership and access to proprietary technology that most other sports supplement companies don't have and must pay to license.
And Muscle Pharm will also benefit from profits made by this developed technology when applied through therapeutic products as well.